Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

France

 

Interview: Stephane Pichon, Your Care Consult

HBI catches up with Stephane Pichon ahead of the Investing in Health Care Property panel at HBI 2023, to discuss the dramatic changes of the past year and how this has impacted health care real estate investment, and the long term outlook for the health care sector.
May 18, 2023

Korian says name change is “not a rebrand”

Last month leading French nursing home operator Korian announced that as of July 1, it will be adopting a new name. Going forward, parent company Korian will be known as ‘Clariane’ - a name HBI understands is designed to evoke clarity and transparency. Is this a reaction to the recent scandals engulfing the sector? Korian claims not. Our sources disagree.
May 17, 2023

FREE BLOG A bientôt Korian, bonjour Clariane!

When an organisation is marred by a reputational scandal so harmful that it jeopardises the bottom line, often a corporate rebrand is the only solution. This course of action is nothing new and there are countless examples of successful makeovers across industries, and health care is no different.
May 12, 2023

Orpea restructuring: What will it look to sell?

It has been almost six months since under-fire French nursing home giant Orpea announced plans to get its core business back on track, restructure its debt, and sell around €1.2bn worth of real estate over the next three years. As discussions separating the wheat from the chaff go on behind closed doors, HBI asks three experts where, and what it might sell, and reviews what other French operators like Korian are doing to repair reputation.
May 5, 2023

Two Korian cooks to face manslaughter charges

Two cooks working for multinational French elderly care giant Korian are being charged with manslaughter over the deaths of five elderly care residents in a food-poisoning incident which took place at one of the group’s French nursing homes in 2019.
April 21, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 
April 19, 2023

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023

Orpea shareholders try to avoid mass dilution

French nursing home giant Orpea’s snubbed shareholders group Concert’O has teamed up with other unsecured lenders in a last-ditch attempt to avoid mass share dilution. Protesting at the operator’s restructuring deal, the group has presented an alternative plan. 
March 31, 2023
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us